Associate Professor Hongchao Pan
Hongchao Pan
MSc PhD
Associate Professor
Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.
Since joining in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies. His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking.
He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine.
Recent publications
nthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk . and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) ., (2023), Lancet, 401, 1277 - 1292
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
Journal article
WHO Solidarity Trial Consortium ., (2022), Lancet, 399, 1941 - 1953
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Journal article
WHO Solidarity Trial Consortium . et al, (2021), N Engl J Med, 384, 497 - 511
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Working paper
PAN H. and Peto R., (2020), MedRxiv
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.
Journal article
Mappin-Kasirer B. et al, (2020), Neurology, 94, e2132 - e2138